Page last updated: 2024-10-22

n-acetyltryptophan and Innate Inflammatory Response

n-acetyltryptophan has been researched along with Innate Inflammatory Response in 4 studies

N-acetyltryptophan : An N-acetylamino acid that is the N-acetyl derivative of tryptophan.

Research Excerpts

ExcerptRelevanceReference
"The neuropeptide substance P (SP) is a well-known mediator of neurogenic inflammation following a variety of CNS disorders."3.80NK1 receptor blockade is ineffective in improving outcome following a balloon compression model of spinal cord injury. ( Leonard, AV; Thornton, E; Vink, R, 2014)

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Saunders, MJ1
Edwards, BS1
Zhu, J1
Sklar, LA1
Graves, SW1
Shim, K1
Gulhar, R1
Jialal, I1
Leonard, AV1
Thornton, E2
Vink, R2

Other Studies

4 other studies available for n-acetyltryptophan and Innate Inflammatory Response

ArticleYear
Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
    Current protocols in cytometry, 2010, Volume: Chapter 13

    Topics: Animals; Biotinylation; Flow Cytometry; Fluorescence Resonance Energy Transfer; Green Fluorescent Pr

2010
Exploratory metabolomics of nascent metabolic syndrome.
    Journal of diabetes and its complications, 2019, Volume: 33, Issue:3

    Topics: Adult; Aged; Biomarkers; Blood Glucose; Blood Pressure; Cardiovascular Diseases; Female; gamma-Amino

2019
NK1 receptor blockade is ineffective in improving outcome following a balloon compression model of spinal cord injury.
    PloS one, 2014, Volume: 9, Issue:5

    Topics: Animals; Blood-Brain Barrier; Disease Models, Animal; Inflammation; Neurokinin-1 Receptor Antagonist

2014
Treatment with a substance P receptor antagonist is neuroprotective in the intrastriatal 6-hydroxydopamine model of early Parkinson's disease.
    PloS one, 2012, Volume: 7, Issue:4

    Topics: Animals; Anti-Inflammatory Agents; Blood-Brain Barrier; Cells; Dopaminergic Neurons; Inflammation; M

2012